Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 48

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 48
---
 |

| ● | Our ability to evaluate and measure our business, prospects and performance metrics; |

| ● | Our ability to compete, directly and indirectly, and succeed in a highly competitive and evolving industry; |

| ● | Our ability to respond and adapt to changes in technology and customer behavior; |

| ● | Our ability to protect our intellectual property and to develop, maintain and enhance a strong brand; and |

| ● | Other factors (including                                                                                              
 the risks contained in the section of this prospectus titled “Risk Factors”) relating to our industry, our operations 
 and results of operations.                                                                                            |

Should one or more of these risks or uncertainties
materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed,
estimated, expected, intended or planned.

Factors or events that could cause our actual
results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results,
levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States,
we do not intend to update any of the forward-looking statements to conform these statements to actual results.

<div align='center'>USE OF PROCEEDS</div>

We estimate that we will receive net proceeds
from this offering of approximately $ , after deducting the
estimated placement agent fees and estimated offering expenses payable by us and assuming no exercise of the Warrants being issued in
this offering. However, because this is a best-efforts offering and there is no minimum offering amount required as a condition to the
closing of this offering, the actual offering amount, the placement agent’s fees and net proceeds to us are not presently determinable
and may be substantially less than the maximum amounts set forth on the cover page of this prospectus.

We currently intend to use the net proceeds from
this offering for working capital and general corporate purposes.

We will retain broad discretion in the allocation
of the net proceeds from this offering and could utilize the proceeds in ways that do not necessarily improve our results of operations
or enhance the value of our common stock.

Pending application of the net proceeds as described
above, we intend to invest the net proceeds of this offering in a money market or other interest-bearing account. The amounts and timing of our actual expenditures will depend upon numerous factors, including our sales and marketing and commercialization efforts, demand for our products, our operating costs and the other factors described under “ Risk Factors” in this prospect